Novel Nanoformulations to Overcome Obstacles in Herbal Drug Delivery for Alzheimer's Disease.
Nanomedicine is a rapidly growing field in pharmaceutical science, driven by the enhanced quality of nano-formulations that improve the treatment of various diseases. Nano-sized novel drug delivery techniques for herbal pharmaceuticals have the potential to enhance activity and address concerns related to medicinal plants in the future. Natural chemicals show promise in various neurodegenerative diseases, but their permeability across the blood-brain barrier prevents them from reaching the nervous system. By improving molecular monitoring, synthesis, and diagnostics, pharmaceutical nanotechnology provides improved controlled drug delivery for the treatment of neurodegeneration. The evaluated and investigated data from recent studies were gathered using Google Scholar as a search engine. We reviewed and analysed research publications from databases like Bentham Science, Elsevier, PubMed, and ScienceDirect, among others, to summarize the findings. Curcumin, Centella asiatica, thymoquinone, Hypericum perforatum, Panax ginseng, quercetin, piperine, and a variety of other herbs and herbal medicines have all been examined for their potential to aid in the treatment of brain disorders like Alzheimer's disease. To enhance drug bioavailability in the brain, nanoformulations, including phytosomes, transferosomes, ethosomes, and niosomes, have been utilized as pharmaceuticals. Herbs and herbal medicines have been synthesized into nanoparticle form to enhance tissue distribution, achieve sustained delivery, and protect against physicochemical degradation while also increasing the solubility and bioavailability of poorly soluble herbal products. To overcome physiological complications, researchers must develop lab-scale approaches, characterization methodologies, and targeting tactics for nanoformulations with high translational potential early in product development.
- Discussion
45
- 10.1016/s0002-9440(10)64777-3
- Feb 1, 2000
- The American Journal of Pathology
The Role of NAC in Amyloidogenesis in Alzheimer's Disease
- Research Article
184
- 10.1016/j.biopsych.2013.08.020
- Oct 6, 2013
- Biological Psychiatry
Psychosis in Alzheimer’s Disease
- Research Article
146
- 10.1016/j.neuron.2014.01.026
- Mar 1, 2014
- Neuron
Intrinsic Connectivity Identifies the Hippocampus as a Main Crossroad between Alzheimer’s and Semantic Dementia-Targeted Networks
- Research Article
233
- 10.1074/jbc.m110.112664
- Jun 1, 2010
- Journal of Biological Chemistry
The amyloid precursor protein (APP) and its proteolytic product amyloid beta (Abeta) are associated with both familial and sporadic forms of Alzheimer disease (AD). Aberrant expression and function of microRNAs has been observed in AD. Here, we show that in rat hippocampal neurons cultured in vitro, the down-regulation of Argonaute-2, a key component of the RNA-induced silencing complex, produced an increase in APP levels. Using site-directed mutagenesis, a microRNA responsive element (RE) for miR-101 was identified in the 3'-untranslated region (UTR) of APP. The inhibition of endogenous miR-101 increased APP levels, whereas lentiviral-mediated miR-101 overexpression significantly reduced APP and Abeta load in hippocampal neurons. In addition, miR-101 contributed to the regulation of APP in response to the proinflammatory cytokine interleukin-1beta (IL-lbeta). Thus, miR-101 is a negative regulator of APP expression and affects the accumulation of Abeta, suggesting a possible role for miR-101 in neuropathological conditions.
- Front Matter
66
- 10.1016/j.jhep.2010.12.003
- Dec 7, 2010
- Journal of Hepatology
Herbal medicine hepatotoxicity: A new step with development of specific biomarkers
- Research Article
37
- 10.1016/j.jphotobiol.2021.112207
- May 5, 2021
- Journal of photochemistry and photobiology. B, Biology
Transcranial photobiomodulation in the management of brain disorders.
- Research Article
193
- 10.2353/ajpath.2008.080434
- Nov 1, 2008
- The American Journal of Pathology
Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
- Research Article
10
- 10.4066/amj.2015.2467
- Jul 31, 2015
- The Australasian medical journal
Herb-drug interaction: The importance of communicating with primary care physicians.
- Research Article
37
- 10.1016/j.ajpath.2011.10.027
- Dec 2, 2011
- The American Journal of Pathology
Rac1b Increases with Progressive Tau Pathology within Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease
- Research Article
23
- 10.2353/ajpath.2007.070015
- Sep 1, 2007
- The American Journal of Pathology
Quantitative Proteomics Identifies Surfactant-Resistant α-Synuclein in Cerebral Cortex of Parkinsonism-Dementia Complex of Guam but Not Alzheimer's Disease or Progressive Supranuclear Palsy
- Research Article
691
- 10.1016/j.neuron.2012.03.004
- Mar 1, 2012
- Neuron
Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome
- Research Article
647
- 10.1016/j.neuron.2009.08.039
- Oct 1, 2009
- Neuron
Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?
- Research Article
137
- 10.1074/jbc.m110.169839
- Jan 1, 2011
- Journal of Biological Chemistry
Glutamate-induced excito-neurotoxicity likely contributes to non-cell autonomous neuronal death in neurodegenerative diseases. Microglial clearance of dying neurons and associated debris is essential to maintain healthy neural networks in the central nervous system. In fact, the functions of microglia are regulated by various signaling molecules that are produced as neurons degenerate. Here, we show that the soluble CX3C chemokine fractalkine (sFKN), which is secreted from neurons that have been damaged by glutamate, promotes microglial phagocytosis of neuronal debris through release of milk fat globule-EGF factor 8, a mediator of apoptotic cell clearance. In addition, sFKN induces the expression of the antioxidant enzyme heme oxygenase-1 (HO-1) in microglia in the absence of neurotoxic molecule production, including NO, TNF, and glutamate. sFKN treatment of primary neuron-microglia co-cultures significantly attenuated glutamate-induced neuronal cell death. Using several specific MAPK inhibitors, we found that sFKN-induced heme oxygenase-1 expression was primarily mediated by activation of JNK and nuclear factor erythroid 2-related factor 2. These results suggest that sFKN secreted from glutamate-damaged neurons provides both phagocytotic and neuroprotective signals.
- Research Article
22
- 10.1111/j.1440-1819.2011.02253.x
- Aug 1, 2011
- Psychiatry and Clinical Neurosciences
Editorial: New drugs for Alzheimer's disease in Japan
- Research Article
301
- 10.1016/j.neuron.2013.01.002
- Jan 1, 2013
- Neuron
Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.